AbbVie Sponsors New BioLabs Facility in Toronto

Dow Jones
04/21
 

By Christopher Kuo

 

AbbVie is sponsoring BioLabs's new 40,000 square-foot lab and office facility in Toronto.

The biopharmaceutical company said Monday that it has agreed to become the founding sponsor of BioLabs University of Toronto to accelerate life sciences research. The facility will be a fully equipped laboratory and collaboration space for up to 30 early stage biotechnology startups, AbbVie said.

As part of its partnership with BioLabs, AbbVie will also offer an annual innovators award to an early stage biotech recipient, granting them mentorship and a year of laboratory and office space, the company said.

"This new facility will help provide Canadian biotech entrepreneurs with the infrastructure, mentorship and collaborative environment needed to translate promising science into real-world health solutions," said Christian Schubert, vice president and global head of AbbVie.

 

Write to Christopher Kuo at chris.kuo@wsj.com

 

(END) Dow Jones Newswires

 

Christian Schubert is vice president and global head of AbbVie Ventures. "AbbVie Sponsors New BioLabs Facility in Toronto," published at 3:25 p.m. ET on April 20, misstated his title.

 

(END) Dow Jones Newswires

April 21, 2026 12:02 ET (16:02 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10